Araliz Lopez

Dr. Araliz Lopez


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ALAraliz Lopez
Araliz Lopez
NLNolasco López
Nolasco López
JLJosé Lozada-Ramírez
José Lozada-Ramírez
MSMartin Alejandro Serrano-Meneses
Martin Alejandro Serrano-Meneses
AOAlicia Ortega
Alicia Ortega
AGAura M. Jiménez Garduño
Aura M. Jiménez Garduño
Parkinson’s disease (PD) is a major health concern, with no accurate or early diagnostic test available for most patients. Chronic inflammation is a recognized contributor to PD pathogenesis; thus, membrane proteins of inflammatory cells such as neutrophils present an accessible target for detecting early molecular changes. In this study, we conducted a theoretical analysis using the GSE99039 database to identify differentially expressed genes (DEGs) in leukocytes from PD patients. From this, we selected nine top candidates for digital polymerase chain reaction (dPCR) analysis in isolated neutrophils from nine PD patients and nine matched controls. Our results revealed significant upregulation of ORAI3 and CLCN2. Unexpectedly, both ACTB (β-actin) and SNCA (alpha-synuclein) were also upregulated in neutrophils. Notably, this study provides the first evidence of CLCN2 expression in neutrophils and demonstrates the significant upregulation of four genes via dPCR. These genes may serve as potential biomarkers for future research on PD detection.